Anadys Pharmaceuticals is a startup based in the United States, most recent round Series-c-plus.
Anadys Pharmaceuticals is a startup based in the United States. Its most recent tracked round is Series-c-plus.
Anadys Pharmaceuticals was a US biopharmaceutical company focused on developing antiviral therapeutics. The company was listed on NASDAQ in 2004.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.